Skip to main content

Table 2 Impact of the prehabilitation program on nutritional parameters

From: Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

 

Control group (n = 15)

Prehabilitation group (n = 14)

p-value

Preoperative HbA1c (%)

5.6 ± 0.6

5.8 ± 0.6

0.382

Intraoperative glucose (BMTest) (mg/dl)

162.7 ± 38.0

154.7 ± 53.5

0.668

Postoperative insulin requirement, n (%)

5 (33.3%)

4 (28.6%)

0.782

Diagnosis

Total protein (g/dl)

6.7 ± 0.7

6.8 ± 0.4

0.510

Albumin (g/dl)

3.9 ± 0.5

3.9 ± 0.4

0.959

Prealbumin (mg/dl)

15.6 ± 6.2

14.2 ± 6.6

0.683

Hemoglobin (g/dl)

12.0 ± 1.8

12.2 ± 1.6

0.843

Preoperative

Total protein (g/dl)

6.8 ± 0.5

7.4 ± 0.3

0.004

Albumin (g/dl)

4.1 ± 0.5

4.4 ± 0.3

0.209

Prealbumin (mg/dl)

20.2 ± 4.9

22.4 ± 4.3

0.428

Hemoglobin (g/dl)

10.8 ± 1.0

10.8 ± 0.9

0.915

Postoperative

Total protein (g/dl)

4.3 ± 0.7

4.9 ± 0.6

0.005

Albumin (g/dl)

2.4 ± 0.6

2.8 ± 0.4

0.021

Prealbumin (mg/dl)

9.5 ± 3.3

12.5 ± 4.3

0.124

Hemoglobin (g/dl)

9.5 ± 1.0

8.9 ± 1.3

0.164

One month postoperative

Total protein (g/dl)

7.0 ± 0.7

7.2 ± 0.5

0.693

Albumin (g/dl)

4.2 ± 0.5

4.2 ± 0.4

0.985

Prealbumin (mg/dl)

20.7 ± 8.2

22.2 ± 5.3

0.465

Hemoglobin (g/dl)

11.2 ± 1.0

11.2 ± 1.4

0.683

  1. Data are presented as mean ± SD, unless otherwise specified